DonaldS.FongMDMPH

Retinal Disease

Chief Medical Officer

Dr. Fong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Donald Fong is an ophthalmologist based in Irwindale, CA, specializing in retinal disease. He completed his residency in ophthalmology at Massachusetts Eye and Ear Infirmary/Harvard Medical School and further trained in vitreoretinal surgery and diabetic eye disease. Dr. Fong also holds an MPH in Quantitative Methods from Harvard School of Public Health. Currently, he is a Retina Specialist at Kaiser Permanente Eye Monitoring Center and serves as Chief Medical Officer at BioCryst Pharmaceuticals. His expertise includes diabetic retinopathy, AMD, myopia, clinical research, epidemiology, and telemedicine. Dr. Fong is a published author with several peer-reviewed articles and has been recognized with awards such as the Innovation Award from the National Business Coalition on Health and the Lawrence Patient Safety Award from Kaiser Permanente.

NIH Clinical CenterClinical Trials, 1993 - 1994
Havard School of Public HealthMPH, Quantitative Methods, 1991 - 1992
Joslin Diabetes CenterFellowship, Diabetic Eye Disease, 1991 - 1992
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1988 - 1991
Newton-Wellesley HospitalInternship, Internal Medicine, 1987 - 1988
The University of Texas Health Science Center at San AntonioClass of 1987